Revvity Inc (BSP:R1VT34)
R$ 23.77 0 (0%) Market Cap: 81.00 Bil Enterprise Value: 93.46 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 65/100

PerkinElmer Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 12:30PM GMT
Release Date Price: R$28.49
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. Welcome to day 1 of the JPMorgan Healthcare Conference. I'm pleased to introduce our first company this morning, PerkinElmer. For those listening in on the webcast, we'll do Q&A after about 20 minutes, and there is a Submit Question function, so please submit questions if you want them addressed during the breakout.

And with that, let me turn it over to Prahlad.

Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director

Good morning. Thank you, Tycho. Good morning, everyone, and thank you for joining us this morning.

Before I share with you the progress PerkinElmer has made over the past 12 months, I wanted to invite your attention to our safe harbor statement and encourage you to visit the Investors section of the PerkinElmer website for additional details.

Starting on Slide 3, while there has been a lot of uncertainty over the past 12 months, we at PerkinElmer have been having a resolute focus on executing on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot